BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 11128682)

  • 1. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
    Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
    J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.
    Pelletier JP; Boileau C; Brunet J; Boily M; Lajeunesse D; Reboul P; Laufer S; Martel-Pelletier J
    Bone; 2004 Mar; 34(3):527-38. PubMed ID: 15003800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
    Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
    Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency.
    Behets C; Williams JM; Chappard D; Devogelaer JP; Manicourt DH
    J Bone Miner Res; 2004 Nov; 19(11):1821-6. PubMed ID: 15476582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
    Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
    J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
    Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
    J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].
    Hu H; Zhang L; Li B; Zhang Y; Liu X; Tian F; Cheng T; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Dec; 23(12):1474-81. PubMed ID: 20073314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
    Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
    Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study.
    Fernandes JC; Martel-Pelletier J; Lascau-Coman V; Moldovan F; Jovanovic D; Raynauld JP; Pelletier JP
    J Rheumatol; 1998 Aug; 25(8):1585-94. PubMed ID: 9712105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1991 Feb; 27():127-30. PubMed ID: 2027112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
    Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
    J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
    Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
    Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.